AU762988B2 - "Novel aminoalkanesulphonic acid derivatives, their production and their use as medicaments" - Google Patents

"Novel aminoalkanesulphonic acid derivatives, their production and their use as medicaments" Download PDF

Info

Publication number
AU762988B2
AU762988B2 AU62190/98A AU6219098A AU762988B2 AU 762988 B2 AU762988 B2 AU 762988B2 AU 62190/98 A AU62190/98 A AU 62190/98A AU 6219098 A AU6219098 A AU 6219098A AU 762988 B2 AU762988 B2 AU 762988B2
Authority
AU
Australia
Prior art keywords
calcium
propanesulphonate
methyl
formula
radical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU62190/98A
Other languages
English (en)
Other versions
AU6219098A (en
Inventor
Jean-Jacques Berthelon
Philippe Durbin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS filed Critical LIPHA SAS
Publication of AU6219098A publication Critical patent/AU6219098A/en
Application granted granted Critical
Publication of AU762988B2 publication Critical patent/AU762988B2/en
Assigned to MERCK SANTE reassignment MERCK SANTE Request to Amend Deed and Register Assignors: LIPHA
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/30—Phosphinic acids [R2P(=O)(OH)]; Thiophosphinic acids ; [R2P(=X1)(X2H) (X1, X2 are each independently O, S or Se)]
    • C07F9/301—Acyclic saturated acids which can have further substituents on alkyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/03—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C309/13—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton
    • C07C309/14—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton
    • C07C309/15—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton containing nitrogen atoms, not being part of nitro or nitroso groups, bound to the carbon skeleton containing amino groups bound to the carbon skeleton the nitrogen atom of at least one of the amino groups being part of any of the groups, X being a hetero atom, Y being any atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/02—Sulfonic acids having sulfo groups bound to acyclic carbon atoms
    • C07C309/24—Sulfonic acids having sulfo groups bound to acyclic carbon atoms of a carbon skeleton containing six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3808—Acyclic saturated acids which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU62190/98A 1998-01-27 1998-01-27 "Novel aminoalkanesulphonic acid derivatives, their production and their use as medicaments" Ceased AU762988B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/FR1998/000147 WO1999037606A1 (fr) 1998-01-27 1998-01-27 Nouveaux derives d'acides aminoalkane sulfoniques, phosphoniques et phosphiniques, leur preparation et leur utilisation comme medicaments

Publications (2)

Publication Number Publication Date
AU6219098A AU6219098A (en) 1999-08-09
AU762988B2 true AU762988B2 (en) 2003-07-10

Family

ID=9521619

Family Applications (1)

Application Number Title Priority Date Filing Date
AU62190/98A Ceased AU762988B2 (en) 1998-01-27 1998-01-27 "Novel aminoalkanesulphonic acid derivatives, their production and their use as medicaments"

Country Status (12)

Country Link
US (1) US6265437B1 (enExample)
EP (1) EP1051393B1 (enExample)
JP (1) JP4156795B2 (enExample)
AT (1) ATE251129T1 (enExample)
AU (1) AU762988B2 (enExample)
CA (1) CA2319272C (enExample)
DE (1) DE69818709T2 (enExample)
DK (1) DK1051393T3 (enExample)
ES (1) ES2209110T3 (enExample)
PT (1) PT1051393E (enExample)
SI (1) SI1051393T1 (enExample)
WO (1) WO1999037606A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070010573A1 (en) * 2003-06-23 2007-01-11 Xianqi Kong Methods and compositions for treating amyloid-related diseases
AR049199A1 (es) * 2004-06-04 2006-07-05 Aventis Pharma Inc Derivados de acido propano-fosfinico sustituido
JP5145537B2 (ja) 2004-12-22 2013-02-20 ビーエイチアイ リミテッド パートナーシップ アミロイド関連疾患を治療するための方法および組成物
FR2899895B1 (fr) * 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP5607930B2 (ja) * 2006-10-12 2014-10-15 ビーエイチアイ リミテッド パートナーシップ ３−アミノ−１−プロパンスルホン酸を送達するための方法、化合物、組成物および媒体
KR100877134B1 (ko) * 2007-05-03 2009-01-09 주식회사 엔지켐 아캄프로세이트 칼슘의 제조방법
WO2009033079A1 (en) * 2007-09-07 2009-03-12 Xenoport, Inc. Externally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200924747A (en) * 2007-09-07 2009-06-16 Xenoport Inc Simple pantoic acid ester neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
TW200932734A (en) * 2007-10-15 2009-08-01 Xenoport Inc Internally masked neopentyl sulfonyl ester cyclization release prodrugs of acamprosate, compositions thereof, and methods of use
DE102008048791A1 (de) * 2008-09-24 2010-03-25 Merck Patent Gmbh Neue Kristallform von Calcium-3-Acetylaminopropan-1-sulfonat
IT1392327B1 (it) * 2008-09-26 2012-02-28 Laboratorio Chimico Int Spa Nuova forma polimorfa del calcio acamprosato

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2384751A1 (fr) * 1977-03-23 1978-10-20 Francaise Coop Pharma Nouveaux derives de la taurine a activite neuro-musculaire renforcee
FR2457281A1 (fr) * 1979-05-23 1980-12-19 Meram Lab Nouveaux derives de l'acide 3-aminopropanesulfonique ayant une activite membranaire renforcee

Also Published As

Publication number Publication date
AU6219098A (en) 1999-08-09
EP1051393B1 (fr) 2003-10-01
EP1051393A1 (fr) 2000-11-15
JP4156795B2 (ja) 2008-09-24
ATE251129T1 (de) 2003-10-15
SI1051393T1 (en) 2004-02-29
US6265437B1 (en) 2001-07-24
CA2319272C (en) 2005-11-08
DK1051393T3 (da) 2004-02-02
ES2209110T3 (es) 2004-06-16
PT1051393E (pt) 2004-02-27
DE69818709T2 (de) 2004-08-19
DE69818709D1 (en) 2003-11-06
JP2002501040A (ja) 2002-01-15
WO1999037606A1 (fr) 1999-07-29
CA2319272A1 (en) 1999-07-29

Similar Documents

Publication Publication Date Title
FI62838B (fi) Foerfarande foer framstaellning av den nya farmaceutiskt anvaendbara hoegerroterande isomeren av en asymmetriskt spiro-hydantoinfoerening
US5278154A (en) New vanadium complexes
AU762988B2 (en) "Novel aminoalkanesulphonic acid derivatives, their production and their use as medicaments"
JPH0213645B2 (enExample)
CH683996A5 (fr) Dérivés aminophosphonates substitués, leur procédé de préparation et compositions pharmaceutiques les contenant.
JP2001504485A (ja) エチレンジアミン三酢酸およびｎ―アシルエチレンジアミン三酢酸銀キレート物
US5196412A (en) Gallium compounds
AU2003266940B2 (en) Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
US4134991A (en) Derivatives of 2-(3-phenyl-2-aminopropionyloxy)-acetic acid
JPS60174792A (ja) メチレンジホスホン酸誘導体、その製造方法および抗リウマチ用薬剤組成物
JPH06503078A (ja) 治療活性を有する４，５−ジヒドロキシ−および４，５，８−トリヒドロキシ−９，１０−ジヒドロ−９，１０−ジオクソ−２−アントラセンカーボキシリック　アシッドジカーボネートおよびウレタン
US4233310A (en) Antiarteriosclerotic N-(mercaptoacyl)-histidines
DE3872213T2 (de) 5-substituierte ornithin-derivate.
JP3125101B2 (ja) 光学異性ヒダントインの分割方法
SU626094A1 (ru) 5-Замещенные производные 5н-дибенз(в, )-азепина, как промежуточные продукты синтеза соединений, обладающих психотропным действием, и способ их получени
WO2011057580A1 (zh) 有机二羧酸和其盐及其制备方法
HU187429B (en) Process for preparing benzylidine derivatives and medical preparatives containing such compounds
KR20000070057A (ko) 리조페린 합성방법
JP2944233B2 (ja) Ｎ−長鎖アシル酸性アミノ酸モノアルカリ塩の製造方法
IE65571B1 (en) Unsaturated aminodicarboxylic acid derivatives
CN112745347B (zh) 一种氨磷汀三水合物的制备方法
US4105791A (en) Hypolipidemic cycloalkylaminobenzoic acids
FR2464257A1 (fr) Triazole-1,2,4 thiols-3 utiles notamment comme medicaments antisecretoires et leur procede de preparation
US4133890A (en) Hypolipidemic compositions and method employing derivatives of 4-(((1,3-benzodioxol-5-yl)methyl)amino)benzoic acid
JPH0841043A (ja) エポキシコハク酸誘導体

Legal Events

Date Code Title Description
DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND TITLE OF INVENTION TO READ "NOVEL AMINOLKANESULPHONIC ACID DERIVATIVES, THEIR PRODUCTION AND THEIR USE AS MEDICAMENTS"

FGA Letters patent sealed or granted (standard patent)